Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, announced the launch of STAgora™, a next-generation infectious disease analytics platform. Designed as a real-time infectious disease intelligence system, the platform combines diagnostic data with advanced statistical modeling and aims to revolutionize how the world detects, monitors, and responds to disease outbreaks.
The STAgora™ platform provides real-time global visualization of infectious disease trends at the municipal, national and continental levels, based on actual diagnostic test results. The platform provides healthcare professionals with immediate, structured diagnostic reports and statistical analysis results in clear, actionable formats, supported by customizable dashboards and real-time alerts.
In addition to tracking individual cases, the STAgora™ platform enables users to track disease outbreaks in specific regions, both locally and internationally. This feature provides visual access to real-time data on disease spread, enhancing situational awareness and supporting timely, data-driven public health responses. By providing national and global health authorities with real-time epidemiological analytics, the platform is intended to strengthen decision-making and support the development of effective response strategies to mitigate the impact of large-scale infectious disease outbreaks.
With over 40 built-in statistical tools, the STAgora™ platform enables early detection of abnormal pathogen patterns and supports predictive modeling of seasonal trends and emerging disease outbreaks. These tools include modules for tracking individual infections, analyzing symptom-based co-infections, and calculating disease trends in real time. Together, they help transform statistical data into actionable insights that guide proactive interventions.
Unlike traditional outbreak monitoring systems that rely on historical data, the STAgora™ platform performs real-time PCR diagnostic analysis, enabling immediate monitoring of pathogen spread and AI-powered algorithms to predict potential future outbreaks.
Also Read: Danaher Names Greg Milosevich as EVP, Life Sciences
“The key differentiator of the STAgora™ platform is its unique architecture, which enables the aggregation of real-time diagnostic data from around the world into a single analytics platform,” said Young-Seag Baeg, chief strategy officer at Seegene.
When combined with Seegene’s proprietary syndromic quantitative PCR diagnostic technology, the STAgora™ platform provides advanced visibility into single-pathogen infections and simultaneous multi-pathogen co-infections. This comprehensive diagnostic information enables clinicians to make faster, more informed decisions at the point of care.
“During the COVID-19 pandemic, we have seen first-hand how important accurate and timely interpretation of diagnostic data is to inform health policy and clinical outcomes,” said Daniel Shin , executive vice president and chief global sales and marketing officer at Seegene. “Today, as we face increasingly complex threats such as antimicrobial resistance, viral mutations, and co-infections, the ability to deliver actionable insights from diagnostic data is a cornerstone of clinical innovation and a vital pillar of global health security.”
Seegene will formally launch the STAgora™ platform at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) Annual Meeting, July 27–31, in Chicago, USA. The event will highlight key platform capabilities, including its integration with CURECA™, Seegene’s fully automated, stand-alone PCR system. The 2025 ADLM Meeting will also serve as a launchpad for Seegene to explore global collaborations and partnerships with healthcare leaders and their customers.
With the launch of the STAgora™ platform, Seegene aims to lay the foundation for a smarter, faster, and more connected global health system. Combining real-time molecular diagnostics, AI-powered analytics, and global data integration, the STAgora™ platform represents a strategic step toward building an intelligent healthcare infrastructure that can proactively respond to emerging threats. The company envisions the platform as a key pillar of the global infectious disease response framework, marking a new step toward improving diagnostic analytics and healthcare preparedness.
Source: PRNewswire